Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide prepared by licensed compounding pharmacies has become an accessible option for people seeking weight loss support outside traditional pharmaceutical channels. The FDA permits 503A compounding facilities to create customized medications when supply constraints exist or personalized dosing is clinically appropriate. PlexusDx works exclusively with accredited compounders to deliver tailored GLP-1 therapy without membership fees or insurance requirements.

How Compounding Pharmacies Create Semaglutide Medications

A compounding pharmacy begins with active pharmaceutical ingredients (APIs) sourced from licensed suppliers, then combines them with sterile diluents and stabilizers in a controlled laboratory environment. Technicians measure each batch according to a specific formula, ensuring accuracy within tight pharmaceutical tolerances. Every compound undergoes quality testing for sterility, potency, and purity before dispensing to patients. This process allows clinicians to adjust doses based on individual response, something mass-manufactured products cannot easily accommodate.

The distinction between 503A and 503B facilities matters: 503A compounders operate under state pharmacy board supervision and prepare medications for specific patients, while 503B facilities manufacture larger batches for broader distribution. PlexusDx exclusively partners with 503A pharmacies to ensure each preparation meets personalized clinical needs. This model supports precision medicine principles, where therapy aligns with a patient's unique metabolism and genetic makeup rather than a one-size-fits-all approach.

Regulatory Framework for Compounded Semaglutide

The FDA has established clear rules permitting compounding pharmacies to prepare semaglutide when there is a documented need—such as supply disruptions or clinical justification for dose customization. Compounders must maintain current licensure, comply with USP <797> and <825> standards for sterility and quality, and keep detailed records of every batch. State pharmacy boards conduct routine inspections to verify compliance, and pharmacists maintain professional liability insurance to protect patients.

Compounded medications are not FDA-approved in the traditional sense; rather, they operate within a regulatory pathway that acknowledges their clinical utility when manufactured under strict oversight. PlexusDx ensures transparency by clearly stating that all its semaglutide products come from licensed 503A compounding pharmacies meeting federal and state standards. Patients receive prescriptions from licensed healthcare providers who evaluate medical history and contraindications before treatment begins.

Personalization Through Genetic Testing and Precision Dosing

Not every person responds identically to semaglutide, partly because genetic variations influence how the body processes GLP-1 receptor signals. The Precision Peptide Genetic Test identifies key variants—such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—that affect appetite regulation and weight metabolism. Testing maps 14 distinct pathways involving 49 peptides and reveals more than 150 genetic insights relevant to weight management. This data allows prescribers to anticipate which doses, formulations, and adjunctive strategies will work best for each patient.

PlexusDx integrates genetic results with compounded dosing flexibility to create truly personalized therapy. A patient with certain FTO variants might benefit from a slower dose escalation, while another with GIPR sensitivity might see faster results at moderate doses. The Precision Peptide Genetic Test ($99 add-on after the first month of treatment) turns a standard weight loss medication into a precision intervention tailored to individual biology. This approach reduces trial-and-error adjustments and helps patients reach effective doses more efficiently.

Cost, Access, and Treatment Options at PlexusDx

PlexusDx offers compounded semaglutide starting at $149 per month, with pricing structured by commitment tier rather than dose level—meaning your dose may need to increase, but your price won't. The company serves all 50 states without requiring insurance, membership fees, or prior authorizations. HSA and FSA accounts are eligible for payment, broadening affordability for many patients. For those preferring oral formulations, PlexusDx provides oral semaglutide at $249 monthly, oral tirzepatide at $279 monthly, or the GLP-Squared Oral combination at $369 monthly.

Patients can also explore the Microdose GLP-1 Protocol at $129 per month for those beginning therapy or seeking a gentler introduction to GLP-1 medications. Tirzepatide—a dual GIP/GLP-1 agonist—is available as a compounded injection starting at $249 monthly or as part of the GLP-Squared combination (semaglutide plus tirzepatide) at $249 monthly for the injection version. PlexusDx's transparent pricing model eliminates surprise costs as treatment progresses, helping patients budget for long-term weight management support.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test starts at $99 add-on. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is semaglutide from a compounding pharmacy as safe as brand-name Ozempic or Wegovy?

Compounded semaglutide prepared by licensed 503A pharmacies meets the same pharmaceutical standards as branded versions when manufactured under USP <797> sterility protocols and state board oversight. The active ingredient is identical; the difference lies in personalized dosing and absence of large-scale marketing expenses.

Why would I need genetic testing if I'm already on semaglutide?

The Precision Peptide Genetic Test reveals whether your genetic makeup favors rapid response, slower titration, or alternative compounds like tirzepatide. Patients with specific GLP1R or GIPR variants sometimes achieve better outcomes with adjusted doses or dual-peptide therapies.

Can I use my FSA or HSA to pay for PlexusDx semaglutide and genetic testing?

Yes, both compounded semaglutide and the Precision Peptide Genetic Test ($99 add-on) qualify as eligible medical expenses under FSA and HSA accounts. PlexusDx accepts these payment methods at checkout, allowing you to use pre-tax healthcare savings to reduce out-of-pocket costs.

What are the most common side effects of compounded semaglutide?

Nausea, mild vomiting, constipation, and decreased appetite are typical during dose escalation and usually diminish after 1–2 weeks at each level. Serious adverse events are rare but include pancreatitis and thyroid concerns in patients with personal or family history of medullary thyroid cancer.

How does the Precision Peptide Genetic Test help me get better weight loss results?

The test identifies 14 pathways and 49 peptides influencing your appetite, energy expenditure, and fat storage—including variants in GLP1R, GIPR, FTO, and MC4R genes. Results guide your prescriber to choose the right starting dose, escalation schedule, and medication type (semaglutide, tirzepatide, or dual therapy) matched to your biology.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves